SF 1029 (see companion bill HF 384) – MinnesotaStatus: In Process
Year Introduced: 2023
This bill prohibits a health plan company from restricting an enrollee’s choice regarding where the enrollee receives services for the diagnosis, monitoring, and treatment of a rare disease or condition, and prohibits cost-sharing or limitations on diagnosing or treating a rare disease or condition that place a greater financial burden on the enrollee or are more restrictive than requirements for in-network care. It also requires medical assistance coverage for diagnosis, monitoring, and treating a rare disease or condition to comply with these requirements.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.